These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
422 related items for PubMed ID: 20041446
1. The Japanese toxicogenomics project: application of toxicogenomics. Uehara T, Ono A, Maruyama T, Kato I, Yamada H, Ohno Y, Urushidani T. Mol Nutr Food Res; 2010 Feb; 54(2):218-27. PubMed ID: 20041446 [Abstract] [Full Text] [Related]
2. Toxicogenomics in predictive toxicology in drug development. Suter L, Babiss LE, Wheeldon EB. Chem Biol; 2004 Feb; 11(2):161-71. PubMed ID: 15123278 [Abstract] [Full Text] [Related]
3. Toxicogenomics in the assessment of immunotoxicity. Baken KA, Vandebriel RJ, Pennings JL, Kleinjans JC, van Loveren H. Methods; 2007 Jan; 41(1):132-41. PubMed ID: 17161310 [Abstract] [Full Text] [Related]
4. The state-of-the-art in predictive toxicogenomics. Fielden MR, Kolaja KL. Curr Opin Drug Discov Devel; 2006 Jan; 9(1):84-91. PubMed ID: 16445120 [Abstract] [Full Text] [Related]
5. The use of toxicogenomic data in risk assessment: a regulatory perspective. Chan VS, Theilade MD. Clin Toxicol (Phila); 2005 Jan; 43(2):121-6. PubMed ID: 15822767 [Abstract] [Full Text] [Related]
14. Identification of genomic biomarkers for concurrent diagnosis of drug-induced renal tubular injury using a large-scale toxicogenomics database. Kondo C, Minowa Y, Uehara T, Okuno Y, Nakatsu N, Ono A, Maruyama T, Kato I, Yamate J, Yamada H, Ohno Y, Urushidani T. Toxicology; 2009 Nov 09; 265(1-2):15-26. PubMed ID: 19761811 [Abstract] [Full Text] [Related]
15. Toxicogenomics: a pivotal piece in the puzzle of toxicological research. Gatzidou ET, Zira AN, Theocharis SE. J Appl Toxicol; 2007 Nov 09; 27(4):302-9. PubMed ID: 17429800 [Abstract] [Full Text] [Related]
16. Toxicogenomics and clinical toxicology: an example of the connection between basic and applied sciences. Ferrer-Dufol A, Menao-Guillen S. Toxicol Lett; 2009 Apr 10; 186(1):2-8. PubMed ID: 19027838 [Abstract] [Full Text] [Related]
17. An FDA perspective on the nonclinical use of the X-Omics technologies and the safety of new drugs. Jacobs A. Toxicol Lett; 2009 Apr 10; 186(1):32-5. PubMed ID: 18809476 [Abstract] [Full Text] [Related]
18. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine. Youns M, Hoheisel JD, Efferth T. Planta Med; 2010 Dec 10; 76(17):2019-25. PubMed ID: 20957595 [Abstract] [Full Text] [Related]
19. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications. Goetz AK, Singh BP, Battalora M, Breier JM, Bailey JP, Chukwudebe AC, Janus ER. Regul Toxicol Pharmacol; 2011 Nov 10; 61(2):141-53. PubMed ID: 21840362 [Abstract] [Full Text] [Related]
20. Pathway analysis tools and toxicogenomics reference databases for risk assessment. Ganter B, Zidek N, Hewitt PR, Müller D, Vladimirova A. Pharmacogenomics; 2008 Jan 10; 9(1):35-54. PubMed ID: 18154447 [Abstract] [Full Text] [Related] Page: [Next] [New Search]